At the Liver Meeting, there was positive news about Rezdiffra for MASH and Vir's Hep delta candidate, along with hope on ...
Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
After over 10 months of being on a liver transplant waitlist, a Kelowna mother is set to get her much needed surgery in early ...
Kelowna mother Lyndsay Richholt was told in March that she has approximately six months to live, her fate now resting on ...
Clinical Trials Arena on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback